Iolyx Therapeutics

Developer of therapeutics for autoimmunity and ophthalmological conditions

placeBurlingame, California, United States calendar_todayFounded 2019 language iolyx.com

Registered entities

Innovation

7 patent families (2 granted) — focus: Human necessities; filing pace accelerating. Cited 172 times.

YearFilings
20221
20233
20244
20256
20262

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital150%
Other / undisclosed150%
Coming soon